|1.||Faye, Babacar: 2 articles (03/2007 - 06/2006)|
|2.||Ndiaye, Mamadou: 2 articles (03/2007 - 06/2006)|
|3.||Dièye, Amadou Moctar: 2 articles (03/2007 - 06/2006)|
|4.||Sy, Guata Yoro: 2 articles (03/2007 - 06/2006)|
|5.||Spiliopoulou, Chara A: 1 article (08/2010)|
|6.||Papoutsis, Ioannis I: 1 article (08/2010)|
|7.||Pistos, Constantinos M: 1 article (08/2010)|
|8.||Athanaselis, Sotirios A: 1 article (08/2010)|
|9.||Nikolaou, Panagiota D: 1 article (08/2010)|
|10.||Maravelias, Constantinos P: 1 article (08/2010)|
09/01/1993 - "The efficacy of bromazepam and prazepam for the different components of anxiety: inhibition, asthenia and somatisation is evaluated in a multi-centric, comparative and randomised study, conducted as double blind and in parallel groups in 159 adult patients showing a manifest anxiety according to the F.D.A. "
|2.||Duodenal Ulcer (Curling's Ulcer)
01/01/1985 - "Fifty out-patients with an active, endoscopically proven duodenal ulcer were entered a double-blind trial of ranitidine + prazepam or ranitidine + placebo. "
01/01/1985 - "Ranitidine versus ranitidine and prazepam in the short-term treatment of duodenal ulcer--a double-blind controlled trial."
01/01/1985 - "It is concluded that prazepam can be usefully combined with ranitidine in the short-term treatment of duodenal ulcer."
|3.||Sleep Initiation and Maintenance Disorders (Insomnia)
12/01/1978 - "Prazepam was statistically significantly superior to placebo as shown on final on-treatment scores for global improvement ratio and for the target symptoms of anxiety, tension, irritability/hostility, depressive mood, insomnia and somatization."
06/01/2006 - "There are not many differences between specialists and generalists except the fact that specialists prefer prazepam in first intention in the insomnia treatment where generalists choose bromazepam. "
06/01/2006 - "With these diseases, the most benzodiazepines prescribed are prazepam against anxiety and insomnia and diazepam against epilepsy. "
03/01/2007 - "The main indications were anxiety, convulsions, epilepsy and insomnia and the benzodiazepines prescribed in first intention were prazepam against anxiety and insomnia and diazepam against convulsions and epilepsy. "
|4.||Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/01/1991 - "Three quarters of the patients were able to take part in the tapering of prazepam doses without exhibiting any reappearance of anxious symptomatology, rebound anxiety, or withdrawal symptoms. "
09/01/1993 - "After a 7 day wash-out period, the patients receive either bromazepam in a 12 mg/d dose or prazepam in a 40 mg/d dose, over 4 weeks (D0-D28), then in a decreasing dose from D28 to D43; follow-up is carried out using the anxious inhibition scale W.P.2, auto-questionnaire A.D.A., the Hamilton anxiety scale and the Tyrer questionnaire (benzodiazepine withdrawal symptoms questionnaire). "
04/01/1992 - "Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children."
08/01/2010 - "The frequent problems associated with the wide use of benzodiazepines, as well as the multiple incidents of poisonings, led to the necessity for the development of a precise, sensitive and rapid method for the simultaneous determination of the 23 most commonly used benzodiazepines (diazepam, nordiazepam, oxazepam, bromazepam, alprazolam, lorazepam, medazepam, flurazepam, fludiazepam, tetrazepam, chlordiazepoxide, clobazam, midazolam, flunitrazepam, 7-amino-flunitrazepam, triazolam, prazepam, nimetazepam, nitrazepam, temazepam, lormetazepam, clonazepam, camazepam) in blood. "